First Mercantile Trust’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,480
| Closed | -$171K | – | 857 |
|
|
2020
Q3 | $171K | Sell |
4,480
-420
| -9% | -$16K | 0.02% | 477 |
|
|
2020
Q2 | $172K | Sell |
4,900
-200
| -4% | -$7.02K | 0.02% | 460 |
|
|
2020
Q1 | $166K | Sell |
5,100
-150
| -3% | -$4.88K | 0.02% | 405 |
|
|
2019
Q4 | $237K | Sell |
5,250
-150
| -3% | -$6.77K | 0.03% | 407 |
|
|
2019
Q3 | $220K | Sell |
5,400
-150
| -3% | -$6.11K | 0.02% | 452 |
|
|
2019
Q2 | $239K | Sell |
5,550
-50
| -0.9% | -$2.15K | 0.03% | 385 |
|
|
2019
Q1 | $215K | Sell |
5,600
-150
| -3% | -$5.76K | 0.05% | 424 |
|
|
2018
Q4 | $203K | Sell |
5,750
-350
| -6% | -$12.4K | 0.05% | 425 |
|
|
2018
Q3 | $235K | Sell |
6,100
-300
| -5% | -$11.6K | 0.05% | 467 |
|
|
2018
Q2 | $209K | Sell |
6,400
-150
| -2% | -$4.9K | 0.04% | 497 |
|
|
2018
Q1 | $179K | Sell |
6,550
-1,400
| -18% | -$38.3K | 0.04% | 530 |
|
|
2017
Q4 | $197K | Sell |
7,950
-14,450
| -65% | -$358K | 0.04% | 545 |
|
|
2017
Q3 | $653K | Buy |
22,400
+850
| +4% | +$24.8K | 0.12% | 216 |
|
|
2017
Q2 | $597K | Sell |
21,550
-34,100
| -61% | -$945K | 0.11% | 231 |
|
|
2017
Q1 | $1.38M | Sell |
55,650
-1,050
| -2% | -$26.1K | 0.21% | 119 |
|
|
2016
Q4 | $1.23M | Sell |
56,700
-1,050
| -2% | -$22.7K | 0.19% | 133 |
|
|
2016
Q3 | $1.37M | Sell |
57,750
-1,500
| -3% | -$35.7K | 0.18% | 142 |
|
|
2016
Q2 | $1.39M | Sell |
59,250
-1,750
| -3% | -$40.9K | 0.17% | 137 |
|
|
2016
Q1 | $1.15M | Hold |
61,000
| – | – | 0.14% | 171 |
|
|
2015
Q4 | $1.13M | Buy |
+61,000
| New | +$1.13M | 0.12% | 218 |
|